Parkinson's genetic testing
- Parkinson's Risk Panel: test to determine the genetic risk of developing Parkinson's disease by analyzing 22 DNA markers.
- Parkinson Genetic Screening87 genetic markers analysis used to identify the potential risk of:
- Parkinson's disease (differentiating whether it is familial, vascular, toxic or traumatic Parkinson's disease).
- Strokes and cerebrovascular accidents (ischemic, transient or hemorrhagic)
Likewise, the genetic screening determines your Pharmacogenetic Profile, which is necessary to identify which pharmacological treatments are most appropriate according to your genetics.
Recommended for those with a family history of Parkinson's disease or who detect incipient symptoms of tremor, rigidity and bradykinesia.